Company intelligence / Profile preview

Glycosan BioSystems

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

Glycosan developed proprietary biocompatible hydrogels that mimic the extracellular matrix, with applications in cell expansion and delivery. The company's HyStem technology was used as a scaffold for mesenchymal stem cell cultivation and transplantation.[4][5]

Therapeutic areas: OphthalmologyNeurologyOtherRheumatology
Modalities: Hydrogel-based drug delivery therapyStem cell therapyCell therapy
Industry: Therapeutic Medical Devices

Partnerships

University of Utah (collaboration with Center for Therapeutic Biomaterials)

Beyond the preview

Go deeper on Glycosan BioSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosan BioSystems.

Explore the full profile